Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 853.27 | 655.20 | 658.29 | 599.55 | 433.42 |
| Operating profit | 139.94 | 91.90 | 113.72 | 113.71 | 71.49 |
| Interest | 0.99 | 3.61 | 3.80 | 5.35 | 7.29 |
| Gross profit | 201.02 | 148.77 | 152.17 | 139.52 | 64.37 |
| EPS (Rs) | 2.95 | 2.27 | 2.54 | 2.40 | 0.93 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 62.07 | 60.48 | 42.25 | 31.16 | 0.17 |
| Stock adjustment | -7.25 | -10.19 | 3.89 | 0.55 | -5.63 |
| Raw material | 407.15 | 338.49 | 327.99 | 291.29 | 209.20 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 77.19 | 56.09 | 60.46 | 54.64 | 48.51 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 236.24 | 178.91 | 152.23 | 139.35 | 109.85 |
| Provisions made | - | - | - | - | - |
| Depreciation | 29.13 | 16.74 | 17.66 | 15.19 | 11.64 |
| Taxation | 38.13 | 29.17 | 30.52 | 25.95 | 14.82 |
| Net profit / loss | 133.76 | 102.87 | 103.99 | 98.38 | 37.90 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.32 | 45.32 | 40.93 | 40.93 | 40.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 16.40 | 14.03 | 17.27 | 18.97 | 16.49 |
| GPM (%) | 21.96 | 20.79 | 21.72 | 22.12 | 14.85 |
| NPM (%) | 14.61 | 14.37 | 14.84 | 15.60 | 8.74 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis